In the present study, we characterized the mechanism of action of the brain-permeable SIRT2 inhibitor AK7 and examined its efficacy in cellular aSyn and mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models of PD. The gene discussed is SIRT2; the disease is Parkinson disease.